Melbourne Clinical Trials
The Shingles Study
The study drug is a potential new vaccine to prevent herpes zoster (shingles).
0 nights
2 vaccine visits + 9 follow-up phone calls + 6 visits
- Study Objective:
- The purpose of this study is to investigate a potential new vaccine for shingles.
- Shingles is a skin rash that causes pain and blistering.
- Understanding Shingles:
- Shingles can lead to long-term nerve pain known as postherpetic neuralgia (PHN).
- PHN may persist for months or years even after the rash has cleared, affecting daily life.
- Importance of Prevention:
- Current treatments for shingles have limited success.
- Therefore, vaccination becomes even more crucial for prevention.
- Clinical Trial Details:
- An independent ethics committee has approved this clinical trial.
- Participants will be reimbursed for their time.
Eligibility
Biological Sex Male or Female
Age 50-59 years old
BMI 18 - 35kg/m²
Medication Stable medications for at least 3 months may be permitted.